Table 2 Correlations between immunological responses and patient characteristics
From: Humoral and cellular response to SARS-CoV-2 BNT162b2 mRNA vaccine in hemodialysis patients
Anti-N (s/co) | Anti-S (AU/mL) | T-cell reactivity (units) | ||||
|---|---|---|---|---|---|---|
Spearman’s rho | P value | Spearman’s rho | P value | Spearman’s rho | P value | |
Age (years) | − 0.123 | 0.395 | − 0.292 | 0.040 | − 0.234 | 0.105 |
BMI (kg/m2) | 0.073 | 0.614 | − 0.162 | 0.262 | − 0.021 | 0.883 |
Dialysis (months) | − 0.059 | 0.682 | − 0.017 | 0.906 | − 0.118 | 0.413 |
S-Albumin (g/L) | − 0.238 | 0.100 | − 0.167 | 0.253 | 0.030 | 0.836 |
Urea before dialysis (mmol/L) | − 0.069 | 0.635 | 0.048 | 0.740 | 0.274 | 0.054 |
Anti-N (s/co) | – | – | 0.490 | < 0.001 | 0.451 | < 0.01 |
Anti-S (AU/mL) | 0.710 | < 0.001 | – | – | 0.481 | < 0.001 |
T-cell react (units) | 0.443 | 0.001 | 0.564 | < 0.001 | – | – |